GNPX Stock Analysis: Buy, Sell, or Hold?
GNPX - Genprex, Inc. Common Stock
$0.72
-0.02 (-2.08%)
▼
5d:
-7.27%
30d:
-23.33%
90d:
-65.22%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When GNPX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GNPX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GNPX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GNPX is currently trading at $0.72, which is considered oversold relative to its 30-day fair value range of $0.77 to $0.90.
Technical Outlook: Technically, GNPX is in a strong downtrend. The price is currently testing key support at $0.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GNPX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.50 (+941.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GNPX is in a strong downtrend. The price is currently testing key support at $0.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GNPX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.50 (+941.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.77 -
$0.90
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 941.8% below Wall St target ($7.50)
- CAUTION: Recommendation downgraded due to -7.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.77 -
$0.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$0.86
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.63
Wall Street Target
$7.50
(+941.8%)
Share & Embed Analysis
Last updated: June 04, 2026 3:04 AM ET
Data refreshes hourly during market hours. Next update: 4:04 AM
Data refreshes hourly during market hours. Next update: 4:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNPX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brent M Longnecker
SELL
8 shares
2026-04-14
Brent M Longnecker
SELL
10 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 51 HOLD |
